- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
IVI Launches 2-Year Health Equity Initiative
The Innovation and Value Initiative (IVI) announced the launch of its Health Equity Initiative, a 2-year initiative that aims to define gaps in value assessment methodology and develop best practices that support health equity.
Alexandria, Virginia — The Innovation and Value Initiative (IVI) announced the launch of its Health Equity Initiative, a 2-year initiative that aims to define gaps in value assessment methodology and develop best practices that support health equity.
The IVI Health Equity Initiative’s goals include:
- Advancing our understanding of why health equity considerations in value assessment are important
- Identifying gaps in data collection and methods practices and implications related to health equity
- Developing “best practice” protocols that inform the practice of value assessment and health technology assessment (HTA) to mitigate these gaps
- Achieving multi-stakeholder consensus about areas for further research, scientific practice change, and policy development
“Through this work, IVI has found that without a consistent and intentional focus on equity, we are blind to key differences among patients. Also, current assessments run the risk of reinforcing or even exacerbating inequities that already exist in the US health care system,” noted Rick Chapman, PhD, chief science officer, IVI.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
